Literature DB >> 8302273

Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.

R L Papke1, S F Heinemann.   

Abstract

As previously reported by Luetje and Patrick [J. Neurosci. 11:837-845 (1991)], the nicotine-like alkaloid cytisine is relatively ineffective in evoking current responses from nicotinic receptors containing the beta 2 subunit. In our experiments, the responses of alpha 4 beta 2- and alpha 3 beta 2-injected oocytes to the application of 1 mM cytisine were only 14.7 +/- 4% and 2.5 +/- 0.8% of the responses to 1 mM acetylcholine (ACh), respectively. Concentration-response relationships for ACh were examined in the presence and absence of cytisine. Although cytisine was relatively ineffective in stimulating current, the coapplication of cytisine and ACh reduced the responses to ACh. For alpha 4 beta 2 receptors, 3 microM cytisine shifted the dose-response curve for ACh to the right, resulting in a 60-fold increase in the apparent EC50 for ACh. For alpha 3 beta 2 receptors, 30 microM cytisine shifted the apparent EC50 for ACh from approximately 150 microM to 1 mM. Although the efficacy of cytisine for alpha 3 beta 2 receptors was very low, cytisine could effectively inhibit the responses of these receptors, with an IC50 of approximately 10 microM. The efficacy of cytisine for alpha 4 beta 2 receptors was greater than that for alpha 3 beta 2 receptors, and it was possible to evaluate the partial agonist properties of cytisine for these receptors. Although the EC50 of cytisine for stimulating current through alpha 4 beta 2 receptors was about 1 microM, concentrations of cytisine as low as 20 nM were able to inhibit 50% of the response to 1 microM ACh. The inhibitory effects of cytisine were reversible over a period of 5 min. Our analysis suggests that cytisine is a true partial agonist for beta 2-containing ACh receptors and as such can inhibit the response of these receptors to ACh through a competitive mechanism. In the case of alpha 4 beta 2 receptors cytisine binds with high apparent affinity and low efficacy to a site shared with ACh, and for alpha 3 beta 2 receptors both the apparent affinity and efficacy of cytisine are relatively low.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8302273

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  60 in total

1.  Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons.

Authors:  C Léna; A de Kerchove D'Exaerde; M Cordero-Erausquin; N Le Novère; M del Mar Arroyo-Jimenez; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  Functional properties of human nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of alpha3beta4 AChRs expressed in permanently transfected HEK cells.

Authors:  M E Nelson; F Wang; A Kuryatov; C H Choi; V Gerzanich; J Lindstrom
Journal:  J Gen Physiol       Date:  2001-11       Impact factor: 4.086

3.  Single channel properties of human alpha3 AChRs: impact of beta2, beta4 and alpha5 subunits.

Authors:  M E Nelson; J Lindstrom
Journal:  J Physiol       Date:  1999-05-01       Impact factor: 5.182

4.  The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.

Authors:  Colin S Cunningham; Lance R McMahon
Journal:  Eur J Pharmacol       Date:  2010-12-21       Impact factor: 4.432

5.  Partial agonists for α4β2 nicotinic receptors stimulate dopaminergic neuron firing with relatively enhanced maximal effects.

Authors:  Ying Chen; Lisa M Broad; Keith G Phillips; Ruud Zwart
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Nicotine Addiction and Psychiatric Disorders.

Authors:  Munir Gunes Kutlu; Vinay Parikh; Thomas J Gould
Journal:  Int Rev Neurobiol       Date:  2015-09-19       Impact factor: 3.230

7.  Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.

Authors:  H Rollema; A Shrikhande; K M Ward; F D Tingley; J W Coe; B T O'Neill; E Tseng; E Q Wang; R J Mather; R S Hurst; K E Williams; M de Vries; T Cremers; S Bertrand; D Bertrand
Journal:  Br J Pharmacol       Date:  2010-03-22       Impact factor: 8.739

Review 8.  A preliminary benefit-risk assessment of varenicline in smoking cessation.

Authors:  Kate Cahill; Lindsay Stead; Tim Lancaster
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Alpha3beta4-nicotinic receptors mediate adrenergic nerve- and peptidergic (CGRP) nerve-dependent vasodilation induced by nicotine in rat mesenteric arteries.

Authors:  S Eguchi; S Miyashita; Y Kitamura; H Kawasaki
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

10.  Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats.

Authors:  Richard L Bell; Bill J A Eiler; Jason B Cook; Shafiqur Rahman
Journal:  Alcohol       Date:  2009-12       Impact factor: 2.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.